Apogee Therapeutics, Inc.
NASDAQ:APGEBiotechnology
+$1.05 today
- Market cap
- $8.36B
- Beta
- 0.62
- P/E (TTM)
- -22.7
- EPS (TTM)
- -$3.94
Volume 0.00M
Average 0.97M
APGE Other Stockholders Equity
Equity items not reported separately, such as additional paid-in capital or treasury stock.
Apogee Therapeutics, Inc.NASDAQ: APGE
Other Stockholders Equity · Q2 FY2026 · quarter ended Jun 2026
Other stockholders equity remains negative
Q2 FY2026 other stockholders equity was $0, compared with $0 a year earlier.
Context
- Other stockholders equity amounted to 0.0% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
- Other stockholders equity increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Stockholders Equity history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Other Stockholders Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
Other Stockholders Equity vs competitors
How APGE compares with its peers on the latest reported figures
- Peers report in different currencies, so other stockholders equity is compared through growth and share of total assets rather than absolute size.
- Other stockholders equity amounts to 0.0% of total assets for APGE, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $1.57B USD | — | — | 149.6% | |
| Sep 2026 | $56.3M USD | -33.6% | +31.1% | 3.3% | |
| Jun 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Sep 2026 | $0 USD | — | — | 0.0% | |
| Jun 2026 | $0 USD | — | — | 0.0% | |
| Jun 2026 | $0 USD | — | — | 0.0% | |
IRONDisc Medicine, Inc. | Sep 2026 | $0 USD | — | — | 0.0% |
| Mar 2026 | $0 USD | -100.0% | — | 0.0% | |
AAPGAscentage Pharma Group International | Dec 2025 | CN¥0 CNY | — | — | 0.0% |
| Peer median (excluding APGE) | — | -66.8% | +31.1% | 0.0% | |
Competitors are the stored peer set for APGE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Apogee Therapeutics, Inc.
NASDAQ:APGE
Intrinsic Alpha fair value
Locked
Current Price
$135.07
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.